CoChat

From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.

Open access
Slavich, George M., Irwin, Michael R. · 2014 · Psychological Bulletin

The DOI matches its Crossref record; 509 of the 509 references it cites were found in a registry or an index; 164 of the 397 sources its claims cite were checked for support.

Abstract

Major life stressors, especially those involving interpersonal stress and social rejection, are among the strongest proximal risk factors for depression. In this review, we propose a biologically plausible, multilevel theory that describes neural, physiologic, molecular, and genomic mechanisms that link experiences of social-environmental stress with internal biological processes that drive depression pathogenesis. Central to this social signal transduction theory of depression is the hypothesis that experiences of social threat and adversity up-regulate components of the immune system involved in inflammation. The key mediators of this response, called proinflammatory cytokines, can in turn elicit profound changes in behavior, which include the initiation of depressive symptoms such as sad mood, anhedonia, fatigue, psychomotor retardation, and social-behavioral withdrawal. This highly conserved biological response to adversity is critical for survival during times of actual physical threat or injury. However, this response can also be activated by modern-day social, symbolic, or imagined threats, leading to an increasingly proinflammatory phenotype that may be a key phenomenon driving depression pathogenesis and recurrence, as well as the overlap of depression with several somatic conditions including asthma, rheumatoid arthritis, chronic pain, metabolic syndrome, cardiovascular disease, obesity, and neurodegeneration. Insights from this theory may thus shed light on several important questions including how depression develops, why it frequently recurs, why it is strongly predicted by early life stress, and why it often co-occurs with symptoms of anxiety and with certain physical disease conditions. This work may also suggest new opportunities for preventing and treating depression by targeting inflammation.

Overview

CoChat Summary

TL;DR

This review proposes a social signal transduction theory of depression in which social threat and adversity up-regulate proinflammatory cytokines through neural, HPA-axis, sympathetic, and genomic pathways, and these cytokines in turn elicit depressive symptoms. It synthesizes evidence linking stress, inflammation, and depression and suggests inflammation-targeted prevention and treatment, while noting that causality and whether inflammation is necessary or sufficient remain unresolved.

Key findings

  • Major life stress is a strong proximal risk factor for major depressive disorder: up to 80% of major depressive episodes in the general population are precipitated by recent major life stress, and up to 44% are preceded by interpersonal loss. In one large study, interpersonal loss initiated by another person conferred a 21.6-fold increase in risk for depression, versus a 10.2-fold increase for self-initiated interpersonal loss; targeted rejection predicted depression onset 3 times faster than other severe life stress.
  • Stress is associated with elevated inflammation. Depressed adults with severe early life stress were 1.48 times more likely to have clinically high CRP (>3 mg/L) than depressed adults without such stress; socially isolated individuals were approximately 2.0–2.5 times more likely to have clinically high CRP; and socially isolated depressed men had CRP and IL-6 levels 2.0 and 3.8 times higher, respectively, than socially integrated nondepressed men.
  • Depression is associated with elevated inflammatory markers, including higher circulating IL-1, IL-6, TNFα, and CRP in otherwise healthy depressed versus nondepressed individuals across at least six meta-analytic reviews. Inflammatory challenges can elicit depressive symptoms: up to 50% of patients receiving chronic IFNα developed clinically significant depression.
  • Anti-inflammatory agents reduced depressive symptoms in randomized trials: reboxetine plus celecoxib produced a 55% reduction in depression severity versus 33% for reboxetine plus placebo, with 75% versus 45% responders; etanercept produced 43% and 55% response rates on HRSD and BDI versus 32% and 39% for placebo; infliximab produced a 62% response rate in patients with baseline CRP >5 mg/L versus 33% for placebo.

Methods

  • Design: narrative review and theoretical integration, not a primary empirical study; the authors synthesize prior literature and propose the social signal transduction theory of depression.
  • Data: reviewed naturalistic, laboratory-based, animal-model, genetic/genomic, neuroimaging, and clinical-trial studies on stress, inflammation, and depression, including meta-analyses and studies of early life stress, adulthood stress, social rejection, cytokines, and anti-inflammatory treatments.
  • Analysis: conceptual model building and narrative synthesis; no new data collection or formal meta-analysis is reported.

Limitations

  • The paper states that there are currently no definitive answers to whether inflammation is necessary and/or sufficient for depression, and that few studies have assessed life stress, inflammation, and depression together in the same study.
  • The paper states that only one study to date has examined neural mechanisms underlying stress-induced inflammatory responding, that no studies have tested for differences in the leukocyte basal transcriptome of depressed versus nondepressed individuals, and that research on antidepressant effects of anti-inflammatory agents is limited.
  • Evident from the text: as a narrative review, it does not report a systematic search strategy or formal quality assessment, and many cited associations are correlational, with substantial variability across inflammation-depression studies noted by the authors.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1037/a0035302

Cites

509 of 509 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

128 Valid · 20 Not valid · 109 Not checked · 111 Own results and interpretations

262 more claims · 96 with their cited sources checked

Create a free account to see all 368 claims and to verify the 2 references still open.

See all claims — free account
  • It may state two separate claims as one. 86
  • Probably not a substantial claim. 18
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

30 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 509 references

Research works printed but not linked: 4

  1. First, MB.; Spitzer, MB.; Gibbon, M.; Williams, JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1995.
  2. Miller NE. Some psychophysiological studies of the motivation and of the behavioral effects of illness. Bulletin of the British Psychological Society. 1964; 17:1-20.
  3. Monroe, SM.; Slavich, GM.; Georgiades, K. The social environment and life stress in depression. In: Gotlib, IH.; Hammen, CL., editors. Handbook of depression. 2. New York, NY: Guilford Press; 2009. p. 340-360.
  4. Wichers M, Maes M. The psychoneuroimmunopathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology. 2002; 5:375-388.10.1017/ S1461145702003103 [PubMed: 12466036]

Cited by

Items 2,201–2,218 of 2,218

Metadata

Authors
Slavich, G. M., & Irwin, M. R.
Affiliations
University of California, Los Angeles (US)
Venue
Psychological Bulletin
Published
2014-05
Volume
140
Issue
3
Pages
774-815
ISSN
  • 0033-2909 (ISSN-L)
  • 1939-1455
OpenAlex
W1980555794
Cited by
2,206
References
499
Citations by year
2026: 231 · 2025: 252 · 2024: 205 · 2023: 209 · 2022: 229 · 2021: 231 · 2020: 168 · 2019: 187 · 2018: 148 · 2017: 117 · 2016: 133 · 2015: 58 · 2014: 35
FWCI
34.99
Type
journal article
Language
en
Open access
Locations
  • Psychological Bulletin (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (R01 CA140933, R01 AG034588, R01 AG026364, R01 CA160245, R01 CA119159, R01 HL095799, R01 DA032922, and P30 AG028748)
  • Society in Science
  • UCLA Clinical and Translational Science Institute (UL1 TR000124)
  • Cousins Center for Psychoneuroimmunology
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
major depressive disorder, social stress, social rejection, inflammatory cytokines, inflammation, depression pathogenesis, early life stress, depression recurrence, anhedonia, social withdrawal, immune system
MeSH terms
Adult, Child, Child, Preschool, Major Depressive Disorder, Female, Humans, Inflammation, Male, Stress, Psychological, Comorbidity, Cytokines, Social Theory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.